Previous Article | Next Article 
Infection and Immunity, May 2004, p. 2810-2816, Vol. 72, No. 5
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.5.2810-2816.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses
Camilo Cuadros, Francisco J. Lopez-Hernandez, Ana Lucia Dominguez, Michael McClelland, and Joseph Lustgarten*
Sidney Kimmel Cancer Center, San Diego, California
Received 4 December 2003/
Returned for modification 14 January 2004/
Accepted 26 January 2004
Vaccination is the most efficient prophylaxis against a variety of infectious diseases. New vaccination strategies rely on the incorporation of effective adjuvants, which stimulate the innate immune response and, in turn, activate the adaptive immune response. It is well established that flagellin induces inflammatory responses through the activation of antigen-presenting cells (APCs). In order to evaluate whether flagellin can serve as a carrier for the development of adjuvants or vaccines, we prepared a flagellin-enhanced green fluorescent protein (EGFP) fusion protein. Our results demonstrate that a flagellin-EGFP fusion protein is capable of stimulating APCs, resulting in the maturation of these cells and secretion of proinflammatory cytokines. Furthermore, APCs pulsed with the flagellin-EGFP fusion protein effectively process and present EGFP antigens. More importantly, animals immunized with the flagellin-EGFP fusion protein developed specific anti-EGFP T-cell responses. In contrast, recombinant EGFP was not able to stimulate APCs, nor did it induce a T-cell response. Thus, recombinant-flagellin fusion proteins may be suitable carriers as adjuvants or vaccines for the development of new vaccination strategies to induce and boost immune responses against infectious diseases and cancer.
* Corresponding author. Mailing address: Joseph Lustgarten, Sidney Kimmel Cancer Center, 10835 Altman Row, San Diego, CA 92121. Phone: (858) 410-4190. Fax: (858) 450-3251. E-mail: jlustgarten{at}skcc.org.
Editor: D. L. Burns
Infection and Immunity, May 2004, p. 2810-2816, Vol. 72, No. 5
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.5.2810-2816.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sharma, S., Dominguez, A. L., Manrique, S. Z., Cavallo, F., Sakaguchi, S., Lustgarten, J.
(2008). Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti-neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice. Cancer Res.
68: 7530-7540
[Abstract]
[Full Text]
-
Wilmanski, J. M., Petnicki-Ocwieja, T., Kobayashi, K. S.
(2008). NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol.
83: 13-30
[Abstract]
[Full Text]
-
Saha, S., Takeshita, F., Matsuda, T., Jounai, N., Kobiyama, K., Matsumoto, T., Sasaki, S., Yoshida, A., Xin, K.-Q., Klinman, D. M., Uematsu, S., Ishii, K. J., Akira, S., Okuda, K.
(2007). Blocking of the TLR5 Activation Domain Hampers Protective Potential of Flagellin DNA Vaccine. J. Immunol.
179: 1147-1154
[Abstract]
[Full Text]
-
Sharma, S., Dominguez, A. L., Lustgarten, J.
(2006). High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged Animals. J. Immunol.
177: 8348-8355
[Abstract]
[Full Text]
-
Buhler, O. T., Wiedig, C. A., Schmid, Y., Grassl, G. A., Bohn, E., Autenrieth, I. B.
(2006). The Yersinia enterocolitica Invasin Protein Promotes Major Histocompatibility Complex Class I- and Class II-Restricted T-Cell Responses. Infect. Immun.
74: 4322-4329
[Abstract]
[Full Text]
-
Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., Menard, S., Balsari, A.
(2006). Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer.. J. Immunol.
176: 6624-6630
[Abstract]
[Full Text]
-
Seya, T., Akazawa, T., Tsujita, T., Matsumoto, M.
(2006). Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies.. Evid Based Complement Alternat Med
3: 31-38
[Abstract]
[Full Text]
-
Lee, S. E., Kim, S. Y., Jeong, B. C., Kim, Y. R., Bae, S. J., Ahn, O. S., Lee, J.-J., Song, H.-C., Kim, J. M., Choy, H. E., Chung, S. S., Kweon, M.-N., Rhee, J. H.
(2006). A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity To Induce Protective Immunity. Infect. Immun.
74: 694-702
[Abstract]
[Full Text]
-
Lopez-Boado, Y. S., Cobb, L. M., Deora, R.
(2005). Bordetella bronchiseptica Flagellin Is a Proinflammatory Determinant for Airway Epithelial Cells. Infect. Immun.
73: 7525-7534
[Abstract]
[Full Text]
-
Pino, O., Martin, M., Michalek, S. M.
(2005). Cellular Mechanisms of the Adjuvant Activity of the Flagellin Component FljB of Salmonella enterica Serovar Typhimurium To Potentiate Mucosal and Systemic Responses. Infect. Immun.
73: 6763-6770
[Abstract]
[Full Text]
-
Applequist, S. E., Rollman, E., Wareing, M. D., Liden, M., Rozell, B., Hinkula, J., Ljunggren, H.-G.
(2005). Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin. J. Immunol.
175: 3882-3891
[Abstract]
[Full Text]
-
Majander, K., Korhonen, T. K., Westerlund-Wikstrom, B.
(2005). Simultaneous Display of Multiple Foreign Peptides in the FliD Capping and FliC Filament Proteins of the Escherichia coli Flagellum. Appl. Environ. Microbiol.
71: 4263-4268
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.